Biodesix to participate in three investor conferences in november

Louisville, colo., oct. 29, 2024 (globe newswire) -- biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer, and robin cowie, chief financial officer, will participate in three upcoming investor conferences:
BDSX Ratings Summary
BDSX Quant Ranking